CFIUS Risk Review Rules May Draw Attention To US Biotech
In October 2018, when the U.S. Department of the Treasury announced the new Committee on Foreign Investment in the United States pilot program addressed to critical technologies, it was first perceived...To view the full article, register now.
Already a subscriber? Click here to view full article